Product image of Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc) supplied by GNH India

Multibic

Active Ingredient:
Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc
Origin:
EU

Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc)

Sodium hydrogen carbonate, the active ingredient in Multibic, is an electrolyte solution presented as a multi‑electrolyte infusion for haemodialysis and intravenous use. It contains magnesium chloride, potassium chloride, sodium chloride and calcium, providing a balanced composition that supports acid‑base regulation and electrolyte homeostasis in patients with renal failure undergoing dialysis.

GNH India supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and dialysis clinics worldwide. The company adheres to European Union manufacturing standards and provides regulatory documentation to support safe clinical use.

Manufacturer / TM Owner

Fresenius Medical Care Deutschland Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Multibic is used in renal replacement therapy to manage electrolyte and acid‑base disturbances during dialysis.

  • Renal failure requiring haemodialysis: maintains plasma sodium, potassium, calcium and magnesium levels to prevent electrolyte imbalance.
  • Haemodialysis procedures: provides buffering capacity to control metabolic acidosis during treatment.
  • Acute kidney injury with electrolyte disturbances: supplies essential ions intravenously to support homeostasis.

How It Works

  • Multibic delivers a balanced mixture of sodium hydrogen carbonate, magnesium chloride, potassium chloride, sodium chloride and calcium directly into the bloodstream or dialysis circuit. The sodium hydrogen carbonate acts as a bicarbonate source, buffering excess hydrogen ions and correcting metabolic acidosis. The accompanying electrolytes replenish plasma concentrations, stabilising membrane potentials and supporting cardiac and neuromuscular function. Together, the solution sustains physiological pH and electrolyte homeostasis throughout haemodialysis.

Side Effects

Multibic may be associated with several adverse reactions, which are categorised by frequency.

Common Side Effects

  • Mild hypotension
  • Nausea or vomiting
  • Transient muscle cramps
  • Slight increase in serum calcium
  • Low‑grade fever

Serious or Rare Side Effects

  • Severe hyperkalemia
  • Severe hypocalcemia
  • Anaphylactic or severe allergic reaction
  • Metabolic alkalosis
  • Cardiac arrhythmia
  • Pulmonary edema

Precautions & Warnings

When using Multibic, clinicians should observe specific precautions to ensure patient safety.

  • Assess electrolyte levels: monitor serum sodium, potassium, calcium and magnesium before and during infusion.
  • Check acid‑base status: evaluate blood pH and bicarbonate to guide dosing.
  • Use with compatible dialysis fluids: verify compatibility with the dialysis machine’s settings and other solutions.
  • Avoid rapid infusion: administer at the prescribed rate to prevent fluid overload and cardiovascular stress.
  • Pregnancy and lactation: consider use only if potential benefits outweigh risks and after specialist consultation.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Multibic can interact with other medicines that affect electrolyte balance or cardiovascular function.

Major Interactions (Avoid)

  • Calcium channel blockers: may increase risk of hypercalcemia.
  • Potassium‑sparing diuretics: can lead to dangerous hyperkalemia.
  • ACE inhibitors or ARBs: additive potassium elevation may occur.

Moderate Interactions (Monitor Closely)

  • Loop diuretics: may cause rapid shifts in sodium and potassium.
  • Beta‑blockers: may mask hypotensive effects of the solution.
  • Blood transfusions: can alter calcium levels and affect coagulation.

Frequently Asked Questions

Multibic is an electrolyte solution used in renal replacement therapy to maintain acid‑base balance and replenish essential ions during haemodialysis or intravenous treatment of patients with renal failure.

Sodium hydrogen carbonate acts as a source of bicarbonate, which buffers excess hydrogen ions in the blood. This helps correct metabolic acidosis that commonly occurs during dialysis, supporting a stable physiological pH.

The prescribed dose of Multibic is individualized by the treating physician based on the patient’s electrolyte profile, acid‑base status, dialysis prescription and overall clinical condition. No fixed regimen is provided.

Safety data for Multibic in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and after specialist consultation.

To order Multibic, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Multibic provides a comprehensive electrolyte profile that includes sodium, potassium, calcium, magnesium and a bicarbonate buffer. Compared with single‑component solutions, it offers broader electrolyte coverage, which can reduce the need for additional supplements during dialysis.

Multibic must be stored at 2‑8 °C, protected from light, and kept in its original container. It should not be frozen or shaken vigorously. Follow all cold‑chain procedures during transport to maintain solution integrity.

Multibic is administered either as an infusion directly into the patient’s bloodstream or added to the dialysis circuit according to the prescribed dialysis protocol. Administration rate and volume are determined by the clinician.

Serious risks include severe hyperkalemia, severe hypocalcemia, anaphylactic reactions, metabolic alkalosis, cardiac arrhythmias and pulmonary edema. Continuous monitoring of electrolytes and patient vitals is essential during treatment.

Multibic should be avoided in patients with known hypersensitivity to any of its components, uncontrolled hyperkalemia, severe hypercalcemia, or in those for whom rapid fluid shifts could cause cardiovascular instability, unless closely monitored.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.